Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome

World News: . []

BOSTON Dec 06 2018 GLOBE NEWSWIRE -- Rhythm Pharmaceuticals Inc NASDAQRYTM a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today announ ced tha...

More news and information about Rhythm Pharmaceuticals, Inc.

Published By:

Globe Newswire: 13:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "rhythm" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us